In TNBC, increases in FOXP3 positive Tregs are associated with improved survival,23,24 but also dismal overall survival in a meta-analysis of unselected breast cancers.25 Ultimately, little is known of FOXP3 expression in Tregs in MBC. The gene discussed is FOXP3; the disease is breast cancer.